EN
HI
Ajanta Pharma Share Price
AJANTPHARM
3307.725.60 (0.78%)
NSE
BSE
Free Demat with Zero AMC*
Open a Free Demat Account
+ Free 1st Year AMC
+ Free 1st Year AMC
Summary
As of 8 Nov, 2026, Ajanta Pharma stock price is ₹3307.7. During the trading session, the stock has moved between an intraday low of ₹3252.10 and an intraday high of ₹3339.50. Over the last 52 weeks, Ajanta Pharma has traded between ₹2445.80 and ₹3796.00.
The stock has recorded a trading volume of 1,42,052 shares,. Its Average Traded Price (ATP) is ₹3304.19, while the Last Traded Quantity at the Last Traded Price (LTQ@LTP) is 1 @ ₹3307.70.
Ajanta Pharma has an upper circuit limit of ₹3969.20 and a lower circuit limit of ₹2646.20. The total value traded stands at ₹46.94 CR, and the delivery percentage for the day is 62.6%.
The stock is currently traded with a market lot size of 1. Ajanta Pharma also offers a dividend yield of 0.85%.
Ajanta Pharma Share Price Chart
Ajanta Pharma Share Key Metrics
Volume
1.42 L
Market Cap
41332.70 CR
LTQ@LTP
1@3307.70
ATP
3304.19
Var Margin
14.46 %
Circuit Range
2646.2-3969.2
Delivery %
62.6 %
Value
46.94 CR
ASM/GSM
No
Market Lot
1
Ajanta Pharma Resistance and Support
Pivot 3299.5
Resistance
First Resistance
3332.6
Second Resistance
3383.1
Third Resistance
3416.2
Support
First Support
3249
Second Support
3215.9
Third Support
3165.4
Ajanta Pharma Shareholding Pattern
View More- 2016-17
- 2018-19
- 2019-20
- 2020-21
- 2021-22
- 2022-23
- 2023-24
- 2024-25
- 2025-26
- 2026-27
Total Promoters
Segment
Percent
Total Promoters
63.47%
Mutual Fund
17.95%
Insurance
3.58%
Foreign Institutional Investors
7.62%
Domestic Institutional Investors
0.42%
Retail
6.96%
Others
0%
Total Promoters
MAR '26
66.25%
JUN '26
63.48%
SEP '26
63.47%
Ajanta Pharma Corporate Actions
| Date | Agenda |
|---|---|
| 2026-10-30 | Quarterly Results |
| 2026-07-30 | Quarterly Results & Interim Dividend |
| 2026-05-05 | Audited Results |
| 2026-01-30 | Quarterly Results |
| 2025-11-03 | Quarterly Results & Interim Dividend |
| 2025-07-28 | Quarterly Results & Others |
| 2025-04-30 | Audited Results & A.G.M. |
| 2025-01-30 | Quarterly Results |
| 2024-10-28 | Quarterly Results |
| Ex Date | Record Date | |
|---|---|---|
| 2026-08-05 | 2026-08-05 | View More |
Ajanta Pharma News
Ajanta Pharma Ltd - 532331 - Board Meeting Outcome for Unaudited Financial Results For The Quarter And Half Year Ended 30.09.2026.
Ajanta Pharma reported Q2 FY27 financial results with cons. revenue increasing by 33% YoY to ₹1,794 crores and net profit rising 49% YoY to ₹388 crores. Adjusted EBITDA grew 47% YoY to ₹543 crores. The US generic segment grew 41% to ₹484 crores while the Africa institution business increased 259% to ₹116 crores.
Oct 30 2026 12:55:07
Ajanta Pharma Ltd - 532331 - Board Meeting Intimation for Considering And Approving Unaudited Financial Results For Q2 FY 2027
Ajanta Pharma board will meet on 30 October 2026 for financial results.
Oct 15 2026 10:28:19
Ajanta Pharma Management
| Name | Position |
|---|---|
| Gaurang Shah | Sr. VP – Legal, Company Secretary & Compliance Officer |
| Mannalal B Agrawal | Chairman |
Ajanta Pharma Similar Stocks
Biocon Ltd.
365.10
3.10 (0.86%)
Gland Pharma Ltd.
3169.30
24.10 (0.77%)
Ipca Laboratories Ltd.
1941.80
-7.80 (0.40%)
Anthem Biosciences Ltd.
915.55
2.00 (0.22%)
Glaxosmithkline Pharmaceuticals Ltd.
2524.80
24.60 (0.98%)
Emcure Pharmaceuticals Ltd.
2212.80
-32.20 (1.43%)
Narayana Hrudayalaya Ltd.
1903.00
-12.50 (0.65%)
Global Health Ltd.
1387.60
-2.10 (0.15%)
Dr. Lal Pathlabs Ltd.
1970.00
3.20 (0.16%)
Ajanta Pharma FAQs
The Buying Price of Ajanta Pharma share is 3307.7 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.
To buy Ajanta Pharma stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Ajanta Pharma, choose your preferred order type, and place the trade.
The Price-to-earnings (P/E) ratio of Ajanta Pharma shares is 32.73. You can compare it with the sector average for relative valuation.
The Price to Book (P/B) ratio Ajanta Pharma shares is 8.51. Useful to assess the stock's value relative to its book value.
To assess Ajanta Pharma’s valuation compare Sector P/E, P/B which are 40.24 & 3.71 with sector averages, along with growth rates and financial metrics.
The Market Cap of Ajanta Pharma is 41332.70 CR. It indicates the company's size category and trading liquidity.
The 52 week high and low prices of Ajanta Pharma share price is 3796.00 & 2445.80. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.
Ajanta Pharma belongs to the Healthcare sector.
Open Your Free
Demat Account Now!
AMC for First Year
Auto Square Off Charges
Open a Free Demat Account
+ Free 1st Year AMC
+ Free 1st Year AMC
13 Lakh+ Clients
Expert-Backed
Premium Tools

Open Your Free
Demat Account Now!
AMC For First Year
Account Opening Fee
Open a Free Demat Account
+ Free 1st Year AMC
+ Free 1st Year AMC
13 Lakh+ Clients
Expert-Backed
Premium Tools
Invest in AJANTPHARM
Account Opening Fee AMC for 1st Year Auto Square Off Charges Call & Trade
Open a Free Demat Account
+ Free 1st Year AMC
+ Free 1st Year AMC
Or Download Choice FinX App
Invest in AJANTPHARM
Account Opening Fee AMC for 1st Year Auto Square Off Charges Call & Trade